Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-024356
Filing Date
2017-04-04
Accepted
2017-04-04 08:08:52
Documents
1
Period of Report
2017-04-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4134
  Complete submission text file 0001209191-17-024356.txt   5710
Mailing Address C/O XENETIC BIOSCIENCES, INC. 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address
PARSLOW JAMES F (Reporting) CIK: 0001285943 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37937 | Film No.: 17736217

Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Issuer) CIK: 0001534525 (see all company filings)

EIN.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations